XBI

Featured

Biotech ETF Breaks Out to All-Time High Before Supreme Court Decision

By John SpenceJune 27, 2012

Featured

Biotech ETFs in ‘Stealth’ Bull Market

By John SpenceMay 31, 2012

Featured

Biotech ETFs for an M&A Boom

By Tom LydonMay 16, 2012

Featured

Biotech ETFs Weather Market Storm

By John SpenceMay 14, 2012

Featured

Choosing the Right Biotech ETF Exposure

By Tom LydonApril 20, 2012

Featured

Biotech ETFs Soar on Human Genome Bid, Gilead Drug Results

By John SpenceApril 19, 2012

Featured

Biotech ETFs Break Out

By John SpenceJanuary 19, 2012

Featured

Teva, Cephalon Boost Biotech ETFs

By John SpenceMay 2, 2011

Featured

April ETF Performance Report

By Tom LydonApril 29, 2011

Featured

Biogen Earnings, Drug Data to Lift Biotech ETFs

By John SpenceApril 21, 2011

Featured

ETFs And A Global Approach Help Investors Access Biotech

By Tom LydonMarch 11, 2011

Featured

5 Biotechnology ETFs to Play Innovation

By Tom LydonFebruary 22, 2011

Featured

ETFs Turn Sunny Side Up on M&A and Earnings

By Tom LydonFebruary 16, 2011

Featured

Sector ETFs to Play the State of the Union Address

By Tom LydonJanuary 26, 2011

Featured

Dissipate the Risk In Biotechnology With ETFs

By Tom LydonJanuary 18, 2011

Featured

Play the Booming Biotech Sector With ETFs

By Tom LydonDecember 21, 2010

Equity ETFs

Deal-Making Drives ETFs Higher

By Tom LydonDecember 21, 2010

Featured

Why Health Care ETFs May Be In the Clear

By Tom LydonNovember 10, 2010

Previous 1 … 12 13 14 15 16 Next